Evaluation of Cognitive Behavioral Therapy for Long-term Pain in Rheumatic Disease, Including Validation of AE-FS

Launched by DIAKONHJEMMET HOSPITAL · May 10, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how Cognitive Behavioral Therapy (CBT) can help people with rheumatic diseases who experience long-term pain. The researchers want to understand how different ways of thinking about pain—like worrying excessively about it or trying to ignore it—affect pain management. They will use a special questionnaire called the Avoidance-Endurance Questionnaire (AE-FS) to measure these thoughts and behaviors. The goal is to see if this questionnaire can help improve the effectiveness of CBT in treating chronic pain.

To join this study, participants need to have a rheumatic disorder and experience long-term pain. They must also be willing to provide written consent. However, if someone is already receiving another therapy during the study, they won't be able to participate. Those who take part can expect to complete several questionnaires at different times during the study: at the start, after treatment ends, and then again two and six months later. This will help researchers assess how well the therapy works over time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • A rheumatic disorder and a long term pain condition
• • Written consent
• Exclusion Criteria:
• • Participation in another therapy during the study periode